Search

everythinglearnresearchcommunity

for

Search:↓

The new drug delivery system effectively targets lung cancer cells.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Five FDA-approved drugs may help block COVID-19 virus entry.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Cepharanthine may help treat COVID-19 by targeting similar pathways as other inflammatory diseases.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Clofazimine effectively treated ashy dermatosis in a patient.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

Baricitinib showed mixed results in treating alopecia areata in children, with some improvement but also side effects.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Tiny particles called anionic squarticles can effectively remove a common antidepressant from the body after an overdose.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

Tofacitinib taken by mouth helps treat hair loss in children.

Valproic acid treatment increases a specific acid in urine by blocking an enzyme, possibly causing skin rash and hair loss.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Semecarpus anacardium leaf extracts may offer safe, effective cancer treatment alternatives.